|
Biographies
of 2005 Fulbright Lifetime Achievement Medal Recipients
Rita E. Hauser
~ John Mendelsohn
~ Hilda Ochoa-Brillembourg
Rita E. Hauser –
Well known as an international lawyer, Dr. Hauser is
President of the Hauser Foundation in New York City. She served on the
President’s Foreign Intelligence Advisory Board and Intelligence Oversight Board
from 2001 to 2004. Dr. Hauser chairs the International Peace Academy, a
research body affiliated with the United Nations, and was the founding chair of
the Advisory Board of the RAND Center for Middle East Public Policy. She serves
as a director of the International Institute for Strategic Studies in London,
the RAND Corporation, and the Lincoln Center for the Performing Arts, among
other organizations. She sits on the Visiting Committee of the John F. Kennedy
School at Harvard University and is vice-chairman of the Dean’s Advisory Board
of Harvard Law School. She serves as co-chair of Harvard University’s endowment
campaign. In 1997, she and her husband founded the Hauser Center for Nonprofit
Organizations at Harvard University, and she is chair of its Advisory Board. A
Fulbright fellow to France in 1954-1955, Dr. Hauser holds advanced degrees from
the University of Strasbourg in France, from Harvard and New York University Law
Schools, and from the University of Paris Law Faculty.
[Return
to top.]
John Mendelsohn
– President of the University of Texas M. D. Anderson
Cancer Center since July 1996, Dr. Mendelsohn has led the center in a period of
phenomenal growth during which it has been named the nation’s top cancer
hospital in four of the past five years by U.S. News & World Report.
Born in Cincinnati, Dr. Mendelsohn earned a bachelor’s degree in biochemical
sciences magna cum laude from Harvard College in 1958. He spent a year in
Scotland as a Fulbright fellow before receiving his medical degree cum laude
from Harvard Medical School in 1963. He was founding director of the Cancer
Center at the University of California, San Diego, and chairman of the
Department of Medicine at Memorial Sloan-Kettering Cancer Center for 11 years.
For three decades, Dr. Mendelsohn has been at the forefront in demonstrating how
growth factors regulate the proliferation of cancer cells by activating
receptors on cell surfaces. He led translational research that developed a
specific monoclonal antibody (cetuximab, Erbitux™) to block the receptor for
epidermal growth factor. Erbitux™ was approved last year by the FDA as a new
treatment of advanced colorectal cancer. He was founding editor-in-chief of
Clinical Cancer Research and has written more than 300 scientific articles
and chapters based on his research.
[Return
to top.]
Hilda
Ochoa-Brillembourg -- Founder and since 1987 President
and Chief Executive Officer of Strategic Investment Group, a group of affiliated
investment management firms, Ms. Ochoa-Brillembourg is also Managing Director of
Emerging Markets Investment Corporation and Emerging Markets Management, LLC.
From 1976 to 1987, she was chief investment officer of the Pension Investment
Division at the World Bank. Prior to joining the World Bank, she served as an
independent consultant in the fields of economics and finance, as a lecturer at
the Universidad Catolica Andres Bello in Venezuela, and as Treasurer of the C.A.
Luz Electrica de Venezuela in Caracas. Ms. Ochoa-Brillembourg is Founding Chair
of the Youth Orchestra of the Americas and chairs the Executive Committee of the
Washington Opera, of which she is a trustee. She is also a director and
Executive Committee member of the National Symphony Orchestra and an Advisory
Board member of the Rockefeller Center for Latin American Studies at Harvard
University. Ms. Ochoa-Brillembourg is a director of the McGraw Hill Companies,
General Mills, Inc., the World Bank/International Monetary Fund Credit Union,
and the Harvard Management Company, Inc. A Fulbright fellow from Venezuela to
Harvard University in 1971 in public administration (MPA 1972), she pursued
doctoral studies in finance from 1972 to 1976 at the Harvard Business School.
[Return to top.] |
